Advice
following an abbreviated submission:
losartan 100mg/hydrochlorothiazide 25mg tablet (Cozaar-Comp 100/25) is accepted for use within NHS Scotland for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled on hydrochlorothiazide or losartan monotherapy.
No increased costs are associated with this product compared with losartan (Cozaar®) 100 mg alone. Compared with a previously available combination product it reduces the tablet burden when higher doses of losartan and hydrochlorothiazide are required.
This fixed dose combination is one of many options for the treatment of hypertension, including other less expensive angiotensin receptor blocker/diuretic combinations.
Download detailed advice28KB (PDF)
Medicine details
- Medicine name:
- losartan hydrochlorothiazide (Cozaar)
- SMC ID:
- 296/06
- Indication:
- hypertension.
- Pharmaceutical company
- MSD
- BNF chapter
- Cardiovascular system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 07 August 2006